Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multi-centre trial analysis revisited

A L Gould1

  • 1Merck Research Laboratories, West Point, PA 19486, USA.

Statistics in Medicine
|September 28, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Strain-level diversity of symbiont communities between individuals and populations of a bioluminescent fish.

The ISME journal·2023
Same author

Chromosome-Level Genome Assembly of the Bioluminescent Cardinalfish Siphamia tubifer: An Emerging Model for Symbiosis Research.

Genome biology and evolution·2022
Same author

Life history of the symbiotically luminous cardinalfish Siphamia tubifer (Perciformes: Apogonidae).

Journal of fish biology·2016
Same author

Segregation effects on the properties of (AuAg)₁₄₇.

Physical chemistry chemical physics : PCCP·2014
Same author

Symbiosis initiation in the bacterially luminous sea urchin cardinalfish Siphamia versicolor.

Journal of fish biology·2012
Same author

Baseline differences in A1C explain apparent differences in efficacy of sitagliptin, rosiglitazone and pioglitazone.

Diabetes, obesity & metabolism·2009
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same journal

Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions.

Statistics in medicine·2026
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
See all related articles

This paper explores advanced statistical methods for analyzing clinical trials conducted across multiple locations. It compares traditional variance analysis techniques with modern Bayesian approaches, which treat site-specific differences as random variables to improve data interpretation and outlier detection.

Area of Science:

  • Statistical methodology within clinical trials research
  • Biostatistics and multi-centre trial analysis applications

Background:

Researchers often struggle to account for site-specific variations when evaluating clinical trial data across diverse geographical locations. Standard statistical models frequently fail to capture the nuances of treatment performance differences between individual sites. This gap motivated the exploration of more flexible analytical frameworks for multi-centre investigations. Prior research has shown that traditional variance analysis often relies on overly restrictive assumptions regarding site effects. That uncertainty drove the need for methods that treat these variations as random rather than fixed parameters. No prior work had resolved how to integrate these advanced techniques into routine practice for clinical researchers. The current literature lacks a straightforward guide for implementing these Bayesian alternatives in standard trial reporting. This study addresses the need for improved statistical rigor in multi-centre data evaluation.

Purpose Of The Study:

This study aims to provide a straightforward framework for applying advanced statistical methods to multi-centre clinical trials. The authors seek to address the limitations of traditional variance analysis in handling site-specific effects. Many researchers currently rely on fixed-effect models that may not adequately capture the complexity of multi-site data. This work explores how empirical and conventional Bayesian approaches can serve as more flexible alternatives. The investigation focuses on integrating these methods into routine practice for clinical trial reporting. By treating centre effects as random variables, the authors aim to improve the accuracy of statistical inferences. The study also explores the utility of graphical displays for identifying outliers in multi-centre datasets. This effort provides a comprehensive guide for researchers looking to enhance their analytical rigor.

Keywords:
biostatisticsclinical trialsvariance analysisstatistical modeling

Frequently Asked Questions

The researchers propose that Bayesian methods, specifically empirical and conventional approaches, provide superior flexibility for multi-centre data. Unlike standard ANOVA, these techniques treat site-specific effects as random variables, allowing for more nuanced modeling of treatment differences across various locations.

The authors utilize Gibbs sampling to construct posterior and predictive distributions. This computational tool enables the generation of complex statistical outputs that are not easily derived from traditional fixed-effect models.

A mixed model approach is necessary when researchers must account for both fixed treatment effects and random centre-specific variations. This structure ensures that the analysis accurately reflects the hierarchical nature of data collected from multiple distinct clinical environments.

Related Experiment Videos

Main Methods:

The review approach involves a comparative evaluation of various statistical models applied to clinical data. Investigators examine the performance of empirical and conventional Bayesian techniques alongside traditional variance analysis. The study design focuses on the integration of random effects to better represent site-specific variability. Researchers incorporate covariates to test the robustness of each statistical framework. The methodology includes the use of Gibbs sampling for constructing predictive distributions. Visual diagnostic tools are developed to assess the joint distribution of site means and standard deviations. The team benchmarks these modern approaches against fixed and mixed model variance analysis. This systematic comparison provides a clear assessment of each method's utility in clinical research.

Main Results:

The empirical Bayesian approach successfully identifies potential outliers through the use of informative graphical displays. These visualizations map individual centre means and standard deviations onto probability contours for clear interpretation. The study finds that Bayesian methods do not require more restrictive assumptions than standard variance analysis. Covariates are integrated into the models without encountering significant technical difficulties. The researchers demonstrate that these approaches are well-understood in related fields like meta-analysis. The results show that Bayesian models provide a convenient mechanism for generating posterior distributions. The comparison reveals that these techniques offer a viable alternative to fixed and mixed model ANOVAs. These findings support the adoption of more flexible statistical frameworks in routine clinical trial analysis.

Conclusions:

The authors suggest that Bayesian methods offer a robust alternative to standard variance analysis for multi-centre data. These approaches allow for the inclusion of covariates without significant computational burden. The empirical Bayesian framework facilitates the creation of visual tools for identifying potential outliers. Gibbs sampling provides a flexible mechanism for generating posterior and predictive distributions for key statistics. The researchers propose that treating site effects as random variables reasonably describes clinical trial outcomes. This perspective remains valid even when sites do not represent a truly random sample. The study demonstrates that these methods are well-suited for routine application in clinical research settings. These findings highlight the potential for improved precision in reporting multi-centre trial results.

Probability contours serve as a critical data type for identifying outliers. By superimposing individual site means and standard deviations onto these contours, investigators can visually detect anomalies that might otherwise remain hidden in standard tabular reports.

The study measures the performance of these models by comparing them against fixed and mixed model ANOVAs. This benchmark allows the authors to evaluate the relative effectiveness of Bayesian techniques in real-world clinical trial datasets.

The authors propose that these Bayesian techniques should be adopted for routine trial reporting. They argue that this shift will lead to more informative graphical displays and more reliable statistical inferences compared to traditional methods.